Canada markets open in 3 hours 19 minutes

Acrivon Therapeutics, Inc. (ACRV)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
8.14-0.09 (-1.09%)
At close: 04:00PM EDT
8.35 +0.21 (+2.58%)
After hours: 04:32PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 254.11M
Enterprise Value 131.29M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)2.10
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -1.97

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-39.48%
S&P500 52-Week Change 326.43%
52 Week High 314.30
52 Week Low 33.19
50-Day Moving Average 37.42
200-Day Moving Average 36.99

Share Statistics

Avg Vol (3 month) 3794.22k
Avg Vol (10 day) 3215.33k
Shares Outstanding 530.88M
Implied Shares Outstanding 631.26M
Float 88.92M
% Held by Insiders 123.06%
% Held by Institutions 169.78%
Shares Short (Apr 15, 2024) 41.03M
Short Ratio (Apr 15, 2024) 40.51
Short % of Float (Apr 15, 2024) 44.49%
Short % of Shares Outstanding (Apr 15, 2024) 43.32%
Shares Short (prior month Mar 15, 2024) 4484.04k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-26.25%
Return on Equity (ttm)-41.41%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -66.57M
Net Income Avi to Common (ttm)-60.39M
Diluted EPS (ttm)-2.74
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)127.46M
Total Cash Per Share (mrq)5.63
Total Debt (mrq)4.64M
Total Debt/Equity (mrq)3.83%
Current Ratio (mrq)9.75
Book Value Per Share (mrq)5.38

Cash Flow Statement

Operating Cash Flow (ttm)-42.64M
Levered Free Cash Flow (ttm)-22.33M